|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
102,087,000 |
Market
Cap: |
N/A |
Last
Volume: |
3,941,702 |
Avg
Vol: |
1,796,900 |
52
Week Range: |
$45.85 - $45.85 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Groninger James G |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$75,840 |
D/D |
2,400 |
23,698 |
|
- |
|
Costa Santo J |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$88,480 |
D/D |
2,800 |
5,600 |
|
- |
|
Tombros Peter G |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$97,960 |
D/D |
3,100 |
16,500 |
|
- |
|
Parks Thomas N |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$91,640 |
D/D |
2,900 |
209,905 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2004-01-05 |
4 |
AS |
$31.07 |
$129,918 |
I/I |
(4,166) |
28,336 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2004-01-05 |
4 |
AS |
$31.16 |
$51,918 |
D/D |
(1,666) |
25,814 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2004-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
|
- |
|
Parks Thomas N |
Director |
|
2004-01-05 |
4 |
AS |
$30.56 |
$131,104 |
I/I |
(4,276) |
26,784 |
|
- |
|
Mueller Alan L |
VP, Drug Discovery |
|
2004-01-02 |
4 |
GA |
$31.36 |
$478,867 |
I/I |
15,270 |
25,470 |
|
- |
|
Mueller Alan L |
VP, Drug Discovery |
|
2004-01-02 |
4 |
D |
$31.36 |
$135,350 |
I/I |
(4,316) |
10,200 |
|
- |
|
Mueller Alan L |
VP, Drug Discovery |
|
2004-01-02 |
4 |
GD |
$31.36 |
$478,867 |
D/D |
15,270 |
0 |
|
- |
|
Mueller Alan L |
VP, Drug Discovery |
|
2004-01-02 |
4 |
OE |
$4.50 |
$14,640 |
I/I |
1,920 |
1,920 |
|
- |
|
Mueller Alan L |
VP, Drug Discovery |
|
2004-01-02 |
4 |
OE |
$4.50 |
$121,013 |
D/D |
13,350 |
13,350 |
|
- |
|
Klein Joseph III |
Director |
|
2004-01-02 |
4 |
OE |
$31.15 |
$62,301 |
D/D |
2,000 |
0 |
|
- |
|
Klein Joseph III |
Director |
|
2004-01-02 |
4 |
OE |
$7.25 |
$14,500 |
D/D |
2,000 |
2,000 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-01-02 |
4 |
AS |
$31.12 |
$93,347 |
D/D |
(3,000) |
18,493 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-01-02 |
4 |
OE |
$4.50 |
$19,025 |
D/D |
3,000 |
21,493 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2003-12-31 |
4 |
GD |
$30.68 |
$33,748 |
D/D |
1,100 |
14,093 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2003-12-31 |
4 |
OE |
$3.00 |
$21,480 |
D/D |
7,160 |
18,493 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2003-12-31 |
4 |
D |
$30.68 |
$21,476 |
D/D |
(700) |
11,333 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2003-12-24 |
4 |
GD |
$31.00 |
$9,300 |
D/D |
300 |
15,193 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2003-12-24 |
4 |
GD |
$31.00 |
$12,400 |
I/I |
400 |
7,341 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2003-12-15 |
4 |
AS |
$32.91 |
$137,124 |
I/I |
(4,166) |
30,419 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2003-12-15 |
4 |
AS |
$32.32 |
$216,406 |
D/D |
(6,666) |
27,480 |
|
- |
|
Parks Thomas N |
Director |
|
2003-12-15 |
4 |
AS |
$32.86 |
$124,171 |
I/I |
(3,776) |
28,672 |
|
- |
|
574 Records found
|
|
Page 18 of 23 |
|
|